These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35312162)

  • 1. BRCA1/2 testing among young women with breast cancer in Massachusetts, 2010-2013: An observational study using state cancer registry and All-Payer claims data.
    Pace LE; Ayanian JZ; Wolf RE; Knowlton R; Gershman ST; Hawkins SS; Keating NL
    Cancer Med; 2022 Jul; 11(13):2679-2686. PubMed ID: 35312162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA1/2 Testing in Massachusetts Among Women With Private Insurance or Medicaid, 2011-2015.
    Pace LE; Baum CF; Horvath K; Raja SC; Cohen J; Hawkins SS
    Med Care; 2020 Nov; 58(11):963-967. PubMed ID: 32925457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment Disparities in Radiation and Hormone Therapy Among Women Covered by Medicaid vs Private Insurance in Cancer Registry and Claims Data.
    Bradley CJ; Sabik LM; Liang R; Lindrooth RC; Perraillon MC
    JAMA Health Forum; 2023 May; 4(5):e230673. PubMed ID: 37145688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer.
    McCarthy AM; Bristol M; Domchek SM; Groeneveld PW; Kim Y; Motanya UN; Shea JA; Armstrong K
    J Clin Oncol; 2016 Aug; 34(22):2610-8. PubMed ID: 27161971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high frequency of BRCA mutations in young black women with breast cancer residing in Florida.
    Pal T; Bonner D; Cragun D; Monteiro AN; Phelan C; Servais L; Kim J; Narod SA; Akbari MR; Vadaparampil ST
    Cancer; 2015 Dec; 121(23):4173-80. PubMed ID: 26287763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial differences in the treatment and outcomes for prostate cancer in Massachusetts.
    Cole AP; Herzog P; Iyer HS; Marchese M; Mahal BA; Lipsitz SR; Nyambose J; Gershman ST; Kennedy M; Merriam G; Rebbeck TR; Trinh QD
    Cancer; 2021 Aug; 127(15):2714-2723. PubMed ID: 33999405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial and ethnic disparities among state Medicaid programs for breast cancer screening.
    Tangka FK; Subramanian S; Mobley LR; Hoover S; Wang J; Hall IJ; Singh SD
    Prev Med; 2017 Sep; 102():59-64. PubMed ID: 28647544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Insurance Status and Racial Disparities With the Detection of Early-Stage Breast Cancer.
    Ko NY; Hong S; Winn RA; Calip GS
    JAMA Oncol; 2020 Mar; 6(3):385-392. PubMed ID: 31917398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.
    Levy DE; Byfield SD; Comstock CB; Garber JE; Syngal S; Crown WH; Shields AE
    Genet Med; 2011 Apr; 13(4):349-55. PubMed ID: 21358336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Racial and Ethnic Disparities in the Use of Medication to Treat Opioid Use Disorder Among Pregnant Women in Massachusetts.
    Schiff DM; Nielsen T; Hoeppner BB; Terplan M; Hansen H; Bernson D; Diop H; Bharel M; Krans EE; Selk S; Kelly JF; Wilens TE; Taveras EM
    JAMA Netw Open; 2020 May; 3(5):e205734. PubMed ID: 32453384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care.
    Freedman RA; Virgo KS; He Y; Pavluck AL; Winer EP; Ward EM; Keating NL
    Cancer; 2011 Jan; 117(1):180-9. PubMed ID: 20939011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.
    Cragun D; Weidner A; Lewis C; Bonner D; Kim J; Vadaparampil ST; Pal T
    Cancer; 2017 Jul; 123(13):2497-2505. PubMed ID: 28182268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
    Kurian AW; Ward KC; Hamilton AS; Deapen DM; Abrahamse P; Bondarenko I; Li Y; Hawley ST; Morrow M; Jagsi R; Katz SJ
    JAMA Oncol; 2018 Aug; 4(8):1066-1072. PubMed ID: 29801090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
    Liu Y; Ide Y; Inuzuka M; Tazawa S; Kanada Y; Matsunaga Y; Kuwayama T; Sawada T; Akashi-Tanaka S; Nakamura S
    Mol Genet Genomic Med; 2019 Mar; 7(3):e493. PubMed ID: 30652428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial and socio-economic disparities in breast cancer hospitalization outcomes by insurance status.
    Akinyemiju T; Sakhuja S; Vin-Raviv N
    Cancer Epidemiol; 2016 Aug; 43():63-9. PubMed ID: 27394678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health insurance coverage and racial disparities in breast reconstruction after mastectomy.
    Shippee TP; Kozhimannil KB; Rowan K; Virnig BA
    Womens Health Issues; 2014; 24(3):e261-9. PubMed ID: 24794541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial and ethnic variation in BRCA1 and BRCA2 genetic test results among individuals referred for genetic counseling at a large urban comprehensive cancer center.
    Abdallah N; Purrington KS; Tatineni S; Assad H; Petrucelli N; Simon MS
    Cancer Causes Control; 2023 Feb; 34(2):141-149. PubMed ID: 36370215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years.
    Malone KE; Daling JR; Doody DR; Hsu L; Bernstein L; Coates RJ; Marchbanks PA; Simon MS; McDonald JA; Norman SA; Strom BL; Burkman RT; Ursin G; Deapen D; Weiss LK; Folger S; Madeoy JJ; Friedrichsen DM; Suter NM; Humphrey MC; Spirtas R; Ostrander EA
    Cancer Res; 2006 Aug; 66(16):8297-308. PubMed ID: 16912212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing participants in the North Carolina Breast and Cervical Cancer Control Program: A retrospective review of 90,000 women.
    Tait SD; Ren Y; Horton CC; Oshima SM; Thomas SM; Wright S; Caesar A; Plichta JK; Hwang ES; Greenup RA; Rosenberger LH; DiLalla GD; Menendez CS; Tolnitch L; Hyslop T; Nelson D; Fayanju OM
    Cancer; 2021 Jul; 127(14):2515-2524. PubMed ID: 33826758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic testing in privately insured women with surgically treated breast cancer.
    Dinan MA; Pitafi S; Greenup RA; Long JB; Gross CP
    Breast Cancer Res Treat; 2023 Feb; 198(1):177-181. PubMed ID: 36542252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.